Type 2 Diabetic Nephropathy
Authors:
Open Access
- 1 March 2005
- journal article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 16 (3) , 574-575
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Temporary Angiotensin II Blockade at the Prediabetic Stage Attenuates the Development of Renal Injury in Type 2 Diabetic RatsJournal of the American Society of Nephrology, 2005
- Preventing Microalbuminuria in Type 2 DiabetesNew England Journal of Medicine, 2004
- The Effect of Irbesartan on the Development of Diabetic Nephropathy in Patients with Type 2 DiabetesNew England Journal of Medicine, 2001
- Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 DiabetesNew England Journal of Medicine, 2001
- Nephropathy in Patients with Type 2 Diabetes MellitusNew England Journal of Medicine, 1999
- Angiotensin-Converting Enzyme Inhibition Delays Onset of Glucosuria With Regression of Renal Injuries in Genetic Rat Model of Non-Insulin-Dependent Diabetes MellitusJournal of Cardiovascular Pharmacology and Therapeutics, 1998
- The role of angiotensin II in diabetic nephropathy: Emphasis on nonhemodynamic mechanismsAmerican Journal of Kidney Diseases, 1997
- Rational drug treatment of the hypertensive diabetic with nephropathyJournal of Diabetic Complications, 1988
- Pathogenesis of diabetic glomerulopathy: Hemodynamic considerationsDiabetes/Metabolism Research and Reviews, 1988
- Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension.Journal of Clinical Investigation, 1986